Clik here to view.
Thank you – new readers and old friends Plus OPK / ROX Dr. Frost Update
This morning my second monitor ( two weeks old HP Pavilion went into sleep mode and won’t recognize the connection to my other screen. Any help would be appreciated. At the same time – I want to say I...
View ArticleClik here to view.
United Natural Foods
UNFI NASDAQ : US$75.39 BUY Target: US$83.00 COMPANY DESCRIPTION United Natural Foods is the leading distributor of natural and organic foods in North America. Raising Target Price Investment...
View ArticleClik here to view.
OPKO Health Oppenheimer Coverage / Rating Outperform
Investment analysts at Oppenheimer assumed coverage on shares of Opko Health (NYSE:OPK) in a note issued to investors on Thursday, Analyst Ratings Network.com reports. The firm set an “outperform”...
View ArticleClik here to view.
SunOpta
STKL : NASDAQ : US$10.72 SOY : TSX BUY Target: US$13.00 COMPANY DESCRIPTION: SunOpta is a vertically integrated supplier of natural/organic ingredients and packaged products. We view SunOpta as one...
View ArticleClik here to view.
OPKO Health News Release – helps stem drift
American Urological Association (AUA) Accepts 4Kscore Test Clinical Study for Plenary Presentation at 2014 Annual Meeting Jack A. Bass Managed accounts holds OPK OPKO HEALTH INC(OPK:NYSE, US)...
View ArticleClik here to view.
Insmed Update
INSM : NASDAQ : US$15.91 BUY Target: US$30.00 COMPANY DESCRIPTION: Insmed is focused on developing novel, targeted inhaled therapies for the treatment of serious orphan lung diseases. Its lead...
View ArticleClik here to view.
TINY New Investment
Much like our interest in Opko Health ( OPK) is a new ( to us ) company that invests in other companies . By not investing in pure research OPK hopes to be at the stage – or closer to the stage of...
View ArticleClik here to view.
Motley Fool Damns OPKO with Faint Praise
Opko Health (NYSE: OPK) – Friday March 28 Finally, we have hybrid diagnostic and pharmaceutical product developer Opko Health, which offers a great degree of promise thanks to a pipeline that spans a...
View ArticleClik here to view.
J&J Update
J&J beats forecasts as new drugs shine, shares jump 1 hour ago – Reuters J&J beats forecasts as new drugs shine, shares jumpBy Ransdell Pierson (Reuters) – Johnson & Johnson <JNJ.N>...
View ArticleClik here to view.
Endologix BUY
ELGX : NASDAQ : US$12.68 BUY Target: US$17.50 COMPANY DESCRIPTION: Endologix develops, manufactures and markets minimally invasive treatments for vascular diseases, namely abdominal aortic aneurysms...
View Article/pic9814888.png)
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/17/balaghat-4-2026-09-17-19-01-31.png)
